Universe · entity
Birchview Capital, LP
Institutional manager (13F) · CIK 1618205
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $169M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | KLA CORPORATION | $29M | 19,883 |
| 2 | BRISTOL-MYERS SQUIBB CO | $19M | 306,268 |
| 3 | COMPASS THERAPEUTICS INC | $8M | 1,465,867 |
| 4 | LAM RESEARCH CORPORATION | $8M | 36,000 |
| 5 | STOKE THERAPEUTICS INC | $7M | 210,000 |
| 6 | OVINTIV INC | $6M | 107,500 |
| 7 | INTELLIA THERAPEUTICS INC | $6M | 445,400 |
| 8 | STRUCTURE THERAPEUTICS INC | $5M | 100,000 |
| 9 | SOLID BIOSCIENCES INC | $5M | 625,980 |
| 10 | PROTHENA CORP PLC | $4M | 449,019 |
| 11 | BIODESIX INC | $4M | 286,804 |
| 12 | ACADIA PHARMACEUTICALS INC | $4M | 171,000 |
| 13 | PROTAGONIST THERAPEUTICS INC | $4M | 35,000 |
| 14 | NEUROCRINE BIOSCIENCES INC | $4M | 27,190 |
| 15 | OLEMA PHARMACEUTICALS INC | $3M | 219,000 |
| 16 | RELMADA THERAPEUTICS INC | $3M | 409,387 |
| 17 | OCULAR THERAPEUTIX INC | $3M | 320,000 |
| 18 | UNITED THERAPEUTICS CORP | $3M | 4,500 |
| 19 | NEKTAR THERAPEUTICS | $2M | 31,000 |
| 20 | CELLDEX THERAPEUTICS INC | $2M | 70,095 |
| 21 | NOVOCURE LTD | $2M | 202,330 |
| 22 | EQT CORPORATION | $2M | 34,619 |
| 23 | PHATHOM PHARMACEUTICALS INC | $2M | 195,000 |
| 24 | BICYCLE THERAPEUTICS PLC | $2M | 463,599 |
| 25 | COMPASS PATHWAYS LTD | $2M | 375,000 |
| 26 | PACIFIC BIOSCIENCES OF CALIFORNIA INC | $2M | 1,500,000 |
| 27 | CYTOKINETICS INC | $2M | 30,000 |
| 28 | CORCEPT THERAPEUTICS INC | $2M | 47,200 |
| 29 | VERA THERAPEUTICS INC | $2M | 44,000 |
| 30 | ALKERMES PLC | $2M | 50,000 |
| 31 | ENGENE HOLDINGS INC | $2M | 250,000 |
| 32 | UNIQURE NV | $2M | 100,697 |
| 33 | ZENAS BIOPHARMA INC | $1M | 70,000 |
| 34 | QUIDELORTHO CORP | $1M | 82,548 |
| 35 | FOGHORN THERAPEUTICS INC | $1M | 281,730 |
| 36 | ULTRAGENYX PHARMACEUTICAL INC | $1M | 62,000 |
| 37 | XENON PHARMACEUTICALS INC | $1M | 21,000 |
| 38 | KALVISTA PHARMACEUTICALS INC | $1M | 57,000 |
| 39 | IMMUNOME INC | $1M | 50,000 |
| 40 | FREEPORT-MCMORAN CL-B | $1M | 18,040 |
| 41 | AXSOME THERAPEUTICS INC | $1M | 6,000 |
| 42 | BIOGEN INC | $917k | 5,000 |
| 43 | LIPOCINE INC | $893k | 111,786 |
| 44 | TRAVERE THERAPEUTICS INC | $868k | 29,200 |
| 45 | HARROW HEALTH INC | $846k | 24,000 |
| 46 | PHARVARIS N V | $843k | 29,847 |
| 47 | VERASTEM INC | $795k | 150,000 |
| 48 | APOGEE THERAPEUTICS INC | $758k | 9,000 |
| 49 | HALOZYME THERAPEUTICS INC | $653k | 10,100 |
| 50 | BRIDGEBIO PHARMA INC | $645k | 8,688 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.